Efficacy and Safety of Glimepiride, Voglibose, and Metformin ER in Type 2 Diabetes: A Randomized, Active‐Controlled Study

Key Points

• The study aims to evaluate the efficacy and safety of glimepiride, voglibose, and metformin in managing type 2 diabetes.
• Conducted as a randomized controlled trial
• Involved multiple active drug comparisons
• Assessed outcomes related to blood sugar levels and safety measures
• Efficacy of each medication in lowering blood glucose levels was evaluated
• Safety profiles of glimepiride, voglibose, and metformin were compared
• Findings suggest potential differences in treatment effectiveness and safety